eloralintide vs tirzepatide (LY3841136), a novel amylin receptor agonist for the treatment of obesity: From discovery to clinical proof of concept Eloralintide Phase 2 Topline results
Pay in 4 interest-free payments of $6.72 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6









.png.jpg)


















